274 related articles for article (PubMed ID: 20688485)
1. Genotypic analysis of plasmid-mediated beta-lactamases amongst Enterobacteriaceae other than Escherichia spp. and Klebsiella spp. that are non-susceptible to a broad-spectrum cephalosporin.
Kiratisin P; Henprasert A
Int J Antimicrob Agents; 2010 Oct; 36(4):343-7. PubMed ID: 20688485
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
3. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
4. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
Livermore DM; Woodford N
Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
[TBL] [Abstract][Full Text] [Related]
5. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
7. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004.
Song W; Kim JS; Kim HS; Yong D; Jeong SH; Park MJ; Lee KM
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):219-24. PubMed ID: 16545935
[TBL] [Abstract][Full Text] [Related]
8. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Pai H; Seo MR; Choi TY
Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
[TBL] [Abstract][Full Text] [Related]
9. Resistance phenotype-genotype correlation and molecular epidemiology of Citrobacter, Enterobacter, Proteus, Providencia, Salmonella and Serratia that carry extended-spectrum β-lactamases with or without plasmid-mediated AmpC β-lactamase genes in Thailand.
Kiratisin P; Henprasert A
Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):46-51. PubMed ID: 20880563
[TBL] [Abstract][Full Text] [Related]
10. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
[TBL] [Abstract][Full Text] [Related]
11. Characterization of TEM-, SHV- and AmpC-type beta-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine.
Rayamajhi N; Kang SG; Lee DY; Kang ML; Lee SI; Park KY; Lee HS; Yoo HS
Int J Food Microbiol; 2008 May; 124(2):183-7. PubMed ID: 18455821
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Nijssen S; Florijn A; Bonten MJ; Schmitz FJ; Verhoef J; Fluit AC
Int J Antimicrob Agents; 2004 Dec; 24(6):585-91. PubMed ID: 15555882
[TBL] [Abstract][Full Text] [Related]
13. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
Pfaller MA; Segreti J
Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
[TBL] [Abstract][Full Text] [Related]
14. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K
Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Potz NA; Hope R; Warner M; Johnson AP; Livermore DM;
J Antimicrob Chemother; 2006 Aug; 58(2):320-6. PubMed ID: 16735428
[TBL] [Abstract][Full Text] [Related]
17. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates from horses.
Vo AT; van Duijkeren E; Fluit AC; Gaastra W
Vet Microbiol; 2007 Oct; 124(3-4):248-55. PubMed ID: 17521833
[TBL] [Abstract][Full Text] [Related]
19. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Mendes RE; Rhomberg PR; Bell JM; Turnidge JD; Sader HS
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):415-25. PubMed ID: 19249175
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
